The influence of rivaroxaban compared to vitamin K antagonist treatment upon development of cardiovascular calcification the IRIVASC-trial

26 August 2022 (08:00 - 19:30)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Robert Stoehr

University Hospital Frankfurt, Frankfurt (Germany)

6 More presentations in this session

Presentation thumbnail

Normal indexed values of left atrial volume by age and gender in a population of 250 healthy subjects: a CT-study.

Doctor B. Alos (Poitiers, FR)

Abstract Slides

Presentation thumbnail

Significance and distribution of aortic valve calcium score before TAVI

Doctor J. Viegas (Lisbon, PT)

Abstract Slides

Presentation thumbnail

Quantification of aortic valve calcification in contrast enhanced computer tomography

Doctor D. Laohachewin (Bad Krozingen, DE)

Abstract Slides

Presentation thumbnail

Evaluation of acute chest pain - is it possible to associate cardiovascular risk scores (TIMI, HEART, GRACE) and the presence of obstructive plaque on coronary computed tomography angiography?

Miss M. Souto (Sao Paulo, BR)

Abstract Slides

Presentation thumbnail

Use of coronary calcium score to refine the cardiovascular risk classification of the new SCORE2 and SCORE2-OP algorithms in patients undergoing coronary CT angiography

Miss M. Paiva (Lisbon, PT)

Abstract Slides

Access the full session

Session thumbnail

More cardiac computed tomography: from morphology to prognosis

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022

You may be interested in

Congress Presentation

Calcium score and CCTA: endgame

Congress Presentation

My Top 5 Cardiovascular CT Papers of 2025

Congress Presentation

State-of-the-art lecture on cardiac computed tomography: innovations for clinical impact

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources